Access for All: How Mobile Visits, Community Sites, and AI Support Diversity Goals in Clinical Trials

As clinical research continues to evolve, the push to secure diverse representation among study participants remains a critical industry goal.

11

June

  • 4PM GMT 12PM EDT'
  • Free

Why attend?

As clinical research continues to evolve, the push to secure diverse representation among study participants remains a critical industry goal. Traditional clinical trial models often face challenges in recruiting and retaining diverse populations due to numerous barriers to participation. Mobile visits and community-based sites offer a promising solution by expanding accessibility and convenience for trial participants, thereby expanding inclusivity for clinical trials worldwide. Attendees will gain insights into the benefits of mobile visits and community-based sites, strategies for implementation to expand accessibility, and the positive impact achieving diversity goals in clinical trials has on clinical research outcomes. Additionally, speakers will explore the potential impact of AI and technology in increasing community engagement and improving overall trial efficiency.

Learning objectives:

  • Understand the importance of diversity in clinical trials and its influence on research outcomes.
  • Examine the challenges traditional clinical models face in recruiting and retaining diverse participant populations.
  • Discover the benefits of mobile visits and community-based sites, supported by new data highlighting their positive impact on accessibility and inclusivity in clinical trials.
  • Identify strategies for the effective implementation of mobile visits and community-based sites.
  • Explore how AI and technology can boost community engagement and broaden patient recruitment and retention in clinical trials

 

 

Speakers

Select a speaker to learn more

Back
Michelle Mallitz, MD
Principal Investigator, EmVenio

Michelle Mallitz, MD, is a Principal Investigator responsible for providing medical and clinical oversight of clinical trials at EmVenio Research community research sites. Dr. Mallitz joined EmVenio Research in 2023 with 25 years of experience in the medical field, with the past 11 years dedicated solely to clinical research. She has worked on over 130 clinical trials in a variety of therapeutic areas and is licensed in 5 states.

Prior to joining EmVenio Research, Dr. Mallitz served as an investigator for various research facilities, most recently at Care Access. Dr. Mallitz earned a Bachelor of Science degree in Molecular Biology from the University of Wisconsin, followed by a Master of Science degree in Human Physiology from Georgetown University and her doctorate from Georgetown University School of Medicine.

Next speaker
Back
Amber Hill, PhD
CEO, Research Grid

Amber Hill, PhD, is a distinguished figure in the intersection of research, global community engagement, and AI technology. She is the founder and CEO of Research Grid (R.grid), a pioneering AI tech company that has developed an automation engine for admin-free clinical trials. Dr. Hill holds a PhD in Biomedical Neuroscience from University College London (UCL), where she also completed a postdoctoral fellowship focusing on widening access to research through AI, supplemented by a stint in Computer Science at Harvard University. Additionally, she has enhanced her leadership skills through a management program at MIT Sloan.

During her time as a student, Dr. Hill founded the nonprofit Movement for Hope, which engages in cross-disciplinary initiatives globally to raise awareness for neurological conditions and broaden access to research. At Research Grid, Dr. Hill leads the development of two innovation products -Inclusive and TrialEngine – which automates back-office tasks for engagement and clinical trials, respectively, streamlining processes to enhance efficiency and accessibility in medical research.

Next speaker
Back
Ellen Weiss (Moderator)
Strategy, Decentralized Trials, Emeritus
PCM Trials

Ellen Weiss connects CROs and sponsors with right-sized hybrid and remote solutions. She has spoken on the logistical support necessary for IMP delivery and dosing, sample collection, and the services provided by clinical trial research nurses that enable alternate-site visits to be carried out with the same data quality and subject safety as on-site visits. Ellen is a member of the Healthcare Businesswomen’s Association and is a volunteer for the American Society of Clinical Oncology.

Next speaker
Back
Tajuana Barron
Vice President of Project Management
PCM Trials

Tajuana Barron is the Vice President of Project Management responsible for project delivery. Ms. Barron joined PCM Trials in 2022 with over 30 years of clinical research experience working for Pharma companies and CROs.

Prior to joining PCM Trials, Ms. Barron served as a Senior Director of Project Management at PPD, where her responsibilities included oversight of a strategic partnership, DCT strategy and management of a team of project directors and managers. Previously, she held leadership roles at PRA and Schering Plough Research Institute. Ms. Barron earned a Bachelor of Science in Chemistry from Bennett College and studied at the University of Medicine & Dentistry of New Jersey.

Next speaker

Enquiry